Jaguar Health Depreciation & Amortization Growth & History (JAGX)
Jaguar Health's depreciation and amortization was $1.9M for fiscal 2025.
View full Jaguar Health company overviewJaguar Health annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.9M | $13,000 | +0.68% |
| 2024 | 2024-12-31 | $1.9M | −$113,000 | −5.61% |
| 2023 | 2023-12-31 | $2.0M | $32,000 | +1.62% |
| 2022 | 2022-12-31 | $2.0M | $262,000 | +15.24% |
| 2021 | 2021-12-31 | $1.7M | −$8,000 | −0.46% |
| 2020 | 2020-12-31 | $1.7M | −$10,000 | −0.58% |
| 2019 | 2019-12-31 | $1.7M | $417,997 | +31.69% |
| 2018 | 2018-12-31 | $1.3M | $734,664 | +125.73% |
| 2017 | 2017-12-31 | $584,339 | $536,845 | +1130.34% |
| 2016 | 2016-12-31 | $47,494 | $42,339 | +821.32% |
| 2015 | 2015-12-31 | $5,155 | — | — |
Jaguar Health quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $473,000 | −$5,000 | −1.05% |
| Q1 2026 | 2026-03-31 | $473,000 | −$6,000 | −1.25% |
| Q4 2025 | 2025-12-31 | $543,000 | — | — |
| Q3 2025 | 2025-09-30 | $479,000 | $5,000 | +1.05% |
| Q2 2025 | 2025-06-30 | $478,000 | $31,000 | +6.94% |
| Q1 2025 | 2025-03-31 | $479,000 | −$22,000 | −4.39% |
| Q3 2024 | 2024-09-30 | $474,000 | −$30,000 | −5.95% |
| Q2 2024 | 2024-06-30 | $447,000 | −$56,000 | −11.13% |
| Q1 2024 | 2024-03-31 | $501,000 | −$3,000 | −0.60% |
| Q3 2023 | 2023-09-30 | $504,000 | $6,000 | +1.20% |
| Q2 2023 | 2023-06-30 | $503,000 | −$55,000 | −9.86% |
| Q1 2023 | 2023-03-31 | $504,000 | $78,000 | +18.31% |
| Q3 2022 | 2022-09-30 | $498,000 | $69,000 | +16.08% |
| Q2 2022 | 2022-06-30 | $558,000 | $128,000 | +29.77% |
| Q1 2022 | 2022-03-31 | $426,000 | −$5,000 | −1.16% |
| Q3 2021 | 2021-09-30 | $429,000 | −$4,000 | −0.92% |
| Q2 2021 | 2021-06-30 | $430,000 | −$1,000 | −0.23% |
| Q1 2021 | 2021-03-31 | $431,000 | −$1,000 | −0.23% |
| Q3 2020 | 2020-09-30 | $433,000 | $1,000 | +0.23% |
| Q2 2020 | 2020-06-30 | $431,000 | −$5,000 | −1.15% |
| Q1 2020 | 2020-03-31 | $432,000 | −$5,000 | −1.14% |
| Q3 2019 | 2019-09-30 | $432,000 | $102,114 | +30.95% |
| Q2 2019 | 2019-06-30 | $436,000 | $106,331 | +32.25% |
| Q1 2019 | 2019-03-31 | $437,000 | $107,439 | +32.60% |
| Q3 2018 | 2018-09-30 | $329,886 | $33,744 | +11.39% |
| Q2 2018 | 2018-06-30 | $329,669 | $314,638 | +2093.26% |
| Q1 2018 | 2018-03-31 | $329,561 | $314,530 | +2092.54% |
| Q3 2017 | 2017-09-30 | $296,142 | $281,111 | +1870.21% |
| Q2 2017 | 2017-06-30 | $15,031 | $5,477 | +57.33% |
| Q1 2017 | 2017-03-31 | $15,031 | $7,153 | +90.80% |
| Q3 2016 | 2016-09-30 | $15,031 | — | — |
| Q2 2016 | 2016-06-30 | $9,554 | — | — |
| Q1 2016 | 2016-03-31 | $7,878 | $7,878 | — |
| Q1 2015 | 2015-03-31 | $0 | — | — |
Jaguar Health depreciation and amortization trends
Over the last five fiscal years, Jaguar Health's depreciation and amortization increased from $1.7M to $1.9M, a change of $186,000. The latest reported quarter, Q2 2026, shows $473,000.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Jaguar Health source filings ↗